Label: BUFFERIN LIDOCAINE PAIN NUMBING- lidocaine hydrochloride cream
- NDC Code(s): 50066-614-27
- Packager: Genomma Lab USA
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated August 21, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients
- Purpose
- Use
-
Warnings
For external use only
Do not use
- in large quantities, particularly over raw surfaces or blistered areas
- on wounds or damaged skin
When using this product
- use only as directed
- avoid contact with eyes
- do not apply tight bandages
- do not apply a heating pad to treated skin
- SPL UNCLASSIFIED SECTION
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 76.5 g Tube Carton
-
INGREDIENTS AND APPEARANCE
BUFFERIN LIDOCAINE PAIN NUMBING
lidocaine hydrochloride creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50066-614 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Lidocaine hydrochloride (UNII: V13007Z41A) (Lidocaine - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS 40 mg in 1 g Inactive Ingredients Ingredient Name Strength Cetyl alcohol (UNII: 936JST6JCN) Water (UNII: 059QF0KO0R) ALOE VERA LEAF (UNII: ZY81Z83H0X) CANNABIS SATIVA SEED OIL (UNII: 69VJ1LPN1S) jojoba oil (UNII: 724GKU717M) DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50066-614-27 1 in 1 CARTON 08/18/2023 1 76.5 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part348 08/18/2023 Labeler - Genomma Lab USA (832323534)